49,024
edits
Difference between revisions of "Plasmacytoid urothelial carcinoma"
Jump to navigation
Jump to search
Plasmacytoid urothelial carcinoma (view source)
Revision as of 17:39, 13 March 2016
, 17:39, 13 March 2016→IHC
(→IHC) |
|||
| Line 73: | Line 73: | ||
*[[CD138]] (15 +ve/16 cases). | *[[CD138]] (15 +ve/16 cases). | ||
*p63 (11 +ve/16 cases). | *p63 (11 +ve/16 cases). | ||
==Molecular== | |||
*CDH1 loss of function - common.<ref name=pmid26901067>{{Cite journal | last1 = Al-Ahmadie | first1 = HA. | last2 = Iyer | first2 = G. | last3 = Lee | first3 = BH. | last4 = Scott | first4 = SN. | last5 = Mehra | first5 = R. | last6 = Bagrodia | first6 = A. | last7 = Jordan | first7 = EJ. | last8 = Gao | first8 = SP. | last9 = Ramirez | first9 = R. | title = Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. | journal = Nat Genet | volume = | issue = | pages = | month = Feb | year = 2016 | doi = 10.1038/ng.3503 | PMID = 26901067 }}</ref> | |||
==See also== | ==See also== | ||